The burden and surveillance of RSV disease in young children in Belgium-expert opinion.
peer reviewed ; UNLABELLED: Infections with respiratory syncytial virus (RSV) can cause severe disease. In young children, RSV is the most common cause of lower respiratory tract illness and life-threatening infections most commonly occur in the first years of life. In adults, elderly and immunocompromised people are most vulnerable. Recently there has been an acceleration in the development of candidate RSV vaccines, monoclonal antibodies and therapeutics which are expected to become available in Europe within the next 2-10 years. Understanding the true burden of childhood RSV disease will be... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | journal article |
Erscheinungsdatum: | 2023 |
Verlag/Hrsg.: |
Springer Science and Business Media Deutschland GmbH
|
Schlagwörter: | Belgium / RSV / Seasonality / Surveillance / Humans / Infant / Newborn / Belgium/epidemiology / Bronchiolitis/epidemiology / Bronchiolitis/virology / Hospitalization / Respiratory Syncytial Virus / Human / Population Surveillance / Respiratory Syncytial Virus Infections/epidemiology / Aged / Bronchiolitis / Child / Preschool / Communicable Diseases / Expert Testimony / Respiratory Syncytial Virus Infections / Pediatrics / Perinatology and Child Health / Human health sciences / Immunology & infectious disease / Sciences de la santé humaine / Pédiatrie / Immunologie & maladie infectieuse |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26985249 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://orbi.uliege.be/handle/2268/299869 |
peer reviewed ; UNLABELLED: Infections with respiratory syncytial virus (RSV) can cause severe disease. In young children, RSV is the most common cause of lower respiratory tract illness and life-threatening infections most commonly occur in the first years of life. In adults, elderly and immunocompromised people are most vulnerable. Recently there has been an acceleration in the development of candidate RSV vaccines, monoclonal antibodies and therapeutics which are expected to become available in Europe within the next 2-10 years. Understanding the true burden of childhood RSV disease will become very important to support public health authorities and policy makers in the assessment of new therapeutic opportunities against RSV disease. A systematic literature search was performed to map local data on the burden of RSV disease and to evaluate available RSV surveillance systems. A group of 9 paediatric infectious diseases specialists participated in an expert panel. The purpose of this meeting was to evaluate and map the burden associated with RSV infection in children, including patient pathways and the epidemiological patterns of virus circulation in Belgium. Sources of information on the burden of RSV disease in Belgium are very limited. For the outpatient setting, it is estimated that 5-10% of young patients seen in primary care are referred to the hospital. Around 3500 children between 0 and 12 months of age are hospitalized for RSV-bronchiolitis every year and represent the majority of all hospitalizations. The current Belgian RSV surveillance system was evaluated and found to be insufficient. Knowledge gaps are highlighted and future perspectives and priorities offered. CONCLUSION: The Belgian population-based RSV surveillance should be improved, and a hospital-led reporting system should be put in place to enable the evaluation of the true burden of RSV disease in Belgium and to improve disease management in the future. WHAT IS KNOWN: • RSV bronchiolitis is a very important cause of infant ...